# Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan

> **NCT00625469** · PHASE4 · WITHDRAWN · sponsor: **Rajan Saggar**

## Conditions studied

- Pulmonary Arterial Hypertension
- Idiopathic Pulmonary Fibrosis

## Interventions

- **DRUG:** bosentan

## Key facts

- **NCT ID:** NCT00625469
- **Lead sponsor:** Rajan Saggar
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-10
- **Primary completion:** 2009-06
- **Final completion:** 2009-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** competing studies did not allow enrollment
- **Last updated:** 2018-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00625469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00625469, "Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00625469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*